(URIROX-2) Establishing the Safety and Efficacy of Reloxaliase (Oxalate Decarboxylase) in Patients with Enteric Hyperoxaluria

The PI of this project was:

This project was funded by: Allena Pharmaceuticals, Inc.

The term of this project was: April 2019 to May 2025

The number of subjects scanned during this project was: 5